Guanze Medical Information Industry (Holding) Co (HKSE:02427) EBIT: HK$-34.15 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02427 Guanze Medical Information Industry (Holding) Co Ltd HKSE:02427
52 GF Score
Price HK$2.80
GF Value HK$0.28
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Guanze Medical Information Industry (Holding) Co EBIT?

Guanze Medical Information Industry (Holding) Co HKSE:02427 +12.00% 52 EBIT is HK$-34.15 Mil as of Dec. 2025. GuruFocus rates HKSE:02427 with a GF Score™ of 52/100 and a GF Value™ of HK$0.28 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Guanze Medical Information Industry (Holding) Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was HK$-39.46 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-34.15 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Guanze Medical Information Industry (Holding) Co's annualized ROC % for the quarter that ended in Dec. 2025 was -16.80%. Guanze Medical Information Industry (Holding) Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -32.35%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Guanze Medical Information Industry (Holding) Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -1.29%.

Guanze Medical Information Industry (Holding) Co  (HKSE:02427) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Guanze Medical Information Industry (Holding) Co's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-46.736 * ( 1 - 7.07% )/( (269.311 + 247.596)/ 2 )
=-43.4317648/258.4535
=-16.80 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=333.456 - 27.008 - ( 37.137 - max(0, 44.274 - 257.336+37.137))
=269.311

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=299.037 - 27.212 - ( 24.229 - max(0, 42.029 - 235.583+24.229))
=247.596

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Guanze Medical Information Industry (Holding) Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-78.92/( ( (71.583 + max(184.086, 0)) + (54.266 + max(177.944, 0)) )/ 2 )
=-78.92/( ( 255.669 + 232.21 )/ 2 )
=-78.92/243.9395
=-32.35 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(151.217 + 25.98 + 34.544) - (27.008 + 0 + 0.64700000000001)
=184.086

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(175.026 + 8.136 + 22.508) - (27.212 + 0 + 0.514)
=177.944

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Guanze Medical Information Industry (Holding) Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-34.147/2651.039
=-1.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guanze Medical Information Industry (Holding) Co EBIT Related Terms

Guanze Medical Information Industry (Holding) Co EBIT Historical Data

* Premium members only.

The historical data trend for Guanze Medical Information Industry (Holding) Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guanze Medical Information Industry (Holding) Co EBIT Chart

Guanze Medical Information Industry (Holding) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial 41.21 34.61 43.22 28.85 -34.09

Guanze Medical Information Industry (Holding) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.83 3.30 25.58 5.31 -39.46

HKSE:02427 vs TMO, DHR, IDXX: EBIT Comparison

For the Diagnostics & Research subindustry, Guanze Medical Information Industry (Holding) Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guanze Medical Information Industry (Holding) Co EV-to-EBIT vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guanze Medical Information Industry (Holding) Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Guanze Medical Information Industry (Holding) Co's EV-to-EBIT falls into.


HKSE:02427
52GF Score
Guanze Medical Information Industry (Holding) Co Ltd HKSE:02427
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guanze Medical Information Industry (Holding) Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-34.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of HK$-34.15 Mil mean?
Guanze Medical Information Industry (Holding) Co (HKSE:02427) has a EBIT of HK$-34.15 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Guanze Medical Information Industry (Holding) Co.
Is Guanze Medical Information Industry (Holding) Co's EBIT too high?
Guanze Medical Information Industry (Holding) Co's current EBIT is HK$-34.15 Mil. Overall, Guanze Medical Information Industry (Holding) Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guanze Medical Information Industry (Holding) Co's EBIT compare to TMO and DHR?
Guanze Medical Information Industry (Holding) Co's EBIT of HK$-34.15 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Diagnostics & Research company?
A good EBIT depends on the Medical Diagnostics & Research industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Guanze Medical Information Industry (Holding) Co. Guanze Medical Information Industry (Holding) Co's current EBIT is HK$-34.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guanze Medical Information Industry (Holding) Co stock overvalued right now?
Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co (HKSE:02427) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.28, compared to a current price of HK$2.80 — trading 900% above its estimated fair value. The current EBIT is HK$-34.15 Mil. Guanze Medical Information Industry (Holding) Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Guanze Medical Information Industry (Holding) Co (HKSE:02427), the current EBIT is HK$-34.15 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guanze Medical Information Industry (Holding) Co (HKSE:02427) Overvalued in 2026?

Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co stock appears to be overvalued. The current stock price of HK$2.80 is trading 900% above its estimated GF Value™ of HK$0.28. GuruFocus considers Guanze Medical Information Industry (Holding) Co to be Significantly Overvalued.

Key valuation signals for HKSE:02427:

  • EBIT: HK$-34.15 Mil
  • GF Value™: HK$0.28 vs. price of HK$2.80 (900% above fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02427 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guanze Medical Information Industry (Holding) Co Business Description

Address No. 2966 Chunhui Road, Room 501-A, Block 10 Strategic Emerging Industry Base, Jinan High-tech Zone, Shandong Province, Jinan, CHN
Guanze Medical Information Industry (Holding) Co Ltd is a medical imaging solutions provider, principally engaged in providing medical imaging film products and medical imaging cloud services in Shandong Province. The company generates the majority of its revenue from the PRC.
52GF Score

Get the complete analysis for HKSE:02427

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.80
Price
HK$0.28
GF Value